sever
arenavirus
caus
hemorrhag
fever
hf
human
evid
indic
worldwidedistribut
prototyp
arenaviru
lymphocyt
choriomening
viru
lcmv
neglect
human
pathogen
clinic
signific
moreov
arenavirus
pose
biodefens
threat
licens
antiarenaviru
vaccin
avail
current
antiarenaviru
therapi
limit
use
ribavirin
partial
effect
associ
anemia
side
effect
therefor
import
develop
effect
vaccin
better
antivir
drug
combat
dual
threat
natur
occur
intent
introduc
arenaviru
infect
develop
arenaviru
revers
genet
system
allow
investig
conduct
detail
molecular
character
viral
cisact
signal
transact
factor
control
step
arenaviru
life
cycl
includ
rna
synthesi
packag
bud
knowledg
deriv
studi
uncov
potenti
novel
target
therapeut
intervent
well
facilit
establish
assay
identifi
character
candid
antivir
drug
capabl
interf
specif
step
viru
life
cycl
likewis
abil
gener
predetermin
specif
mutat
within
arenaviru
genom
analyz
phenotyp
express
would
significantli
contribut
elucid
arenavirushost
interact
includ
basi
abil
caus
sever
hf
turn
could
lead
develop
novel
potent
safe
arenaviru
vaccin
ribovirus
virus
rna
genom
contain
largest
number
virus
signific
impact
human
health
sever
agent
associ
signific
biohazard
concern
manipul
highest
biosafeti
level
condit
complic
research
aim
understand
biolog
pathogenesi
well
identif
character
antivir
drug
combat
term
revers
genet
use
field
molecular
virolog
refer
gener
rescu
virus
entir
clone
cdna
approach
first
implement
gener
genet
manipul
posit
strand
rna
virus
whose
deprotein
genom
abl
act
mrna
initi
viru
life
cycl
deliv
appropri
suscept
cell
contrast
templat
polymeras
neg
strand
ns
rna
virus
exclus
nucleocapsid
consist
genom
rna
tightli
encapsid
viru
nucleoprotein
n
associ
viru
polymeras
protein
form
ribonucleoprotein
rnp
complex
rnp
activ
transcript
replic
minimum
unit
infect
consequ
deprotein
genom
ns
rna
virus
function
mrna
infecti
thu
gener
biolog
activ
synthet
ns
virus
cdna
requir
tran
complement
viral
protein
involv
viru
replic
transcript
consider
initi
pose
uniqu
hurdl
develop
revers
genet
system
ns
rna
virus
neumann
et
al
conzelmann
howev
last
year
follow
pioneer
work
pales
group
luytj
et
al
signific
progress
made
area
revers
genet
system
develop
riboviru
famili
develop
revolution
analysi
cisact
sequenc
transact
protein
requir
viru
replic
transcript
assembl
cell
egress
addit
develop
pave
way
engin
virus
vaccin
gene
therapi
purpos
moreov
use
revers
genet
approach
possibl
develop
cellbas
minireplicon
minigenom
mg
assay
conduct
studi
condit
dissect
mani
aspect
molecular
cell
biolog
associ
life
cycl
virus
mgbase
assay
also
provid
foundat
develop
novel
screen
strategi
identifi
valid
compound
could
potenti
develop
effect
antivir
drug
arenavirus
caus
chronic
infect
rodent
worldwid
distribut
asymptomat
infect
anim
move
freeli
natur
habitat
may
invad
human
dwell
human
infect
like
mucos
exposur
aerosol
direct
contact
infecti
materi
abrad
skin
infect
common
case
sever
famili
arenavirida
consist
one
uniqu
genu
arenaviru
recogn
speci
classifi
two
distinct
group
old
world
ow
new
world
nw
classif
origin
establish
base
serolog
crossreact
well
support
recent
sequencebas
phylogenet
studi
genet
ow
arenavirus
constitut
singl
lineag
nw
arenavirus
segreg
clade
b
c
ow
arenaviru
lassa
viru
lasv
sever
nw
arenavirus
includ
junin
viru
junv
caus
hemorrhag
fever
hf
human
repres
seriou
public
health
problem
endem
area
mccormick
fisherhoch
peter
geisbert
jahrl
buchmeier
et
al
enria
et
al
khan
et
al
tabl
lasv
estim
infect
sever
hundr
thousand
individu
yearli
endem
region
west
africa
highest
incid
affect
mano
river
union
mru
countri
result
high
number
lassa
fever
lf
case
associ
signific
mortal
high
morbid
khan
et
al
recent
year
increas
air
travel
africa
area
led
import
case
unit
state
europ
japan
canada
holm
et
al
freedman
woodal
isaacson
junv
endem
humid
pampa
argentin
caus
argentin
hf
ahf
left
untreat
high
casefat
rate
enria
et
al
moreov
worth
note
compel
evid
indic
worldwidedistribut
prototyp
arenaviru
lcmv
neglect
human
pathogen
clinic
signific
especi
case
congenit
infect
lead
hydrocephalu
mental
retard
chorioretin
infant
jahrl
peter
met
met
et
al
barton
et
al
addit
lcmv
pose
special
threat
immunocompromis
individu
tragic
illustr
recent
case
transplantassoci
infect
lcmv
fatal
outcom
usa
fischer
et
al
peter
arenaviru
potenti
persontoperson
transmiss
togeth
likelihood
aerosol
form
virus
would
highli
infecti
human
led
inclus
hf
arenavirus
lcmv
within
categori
biolog
agent
pose
signific
biodefens
concern
borio
et
al
concern
aggrav
lack
licens
vaccin
effect
treatment
therefor
import
develop
novel
effect
antiarenaviru
therapi
vaccin
evid
indic
morbid
mortal
associ
lasv
infect
like
hf
arenaviru
infect
associ
least
partli
failur
host
innat
immun
respons
restrict
viru
replic
facilit
initi
effect
adapt
immun
respons
mccormick
fisherhoch
accordingli
extent
viremia
highli
predict
factor
outcom
lf
patient
scenario
would
suggest
therapeut
intervent
result
reduc
viru
load
might
suffic
despit
lack
complet
viru
clearanc
promot
recoveri
appropri
host
defens
respons
control
viru
multipl
associ
diseas
besid
signific
human
health
arenavirus
also
import
model
system
studi
virushost
interact
studi
use
prototyp
arenaviru
lcmv
led
major
advanc
virolog
immunolog
appli
univers
microbi
infect
viral
infect
human
oldston
zinkernagel
outcom
lcmv
infect
natur
host
mous
vari
dramat
depend
speci
age
immun
statu
genet
background
host
well
rout
infect
strain
dose
infect
viru
oldston
zinkernagel
buchmeier
et
al
provid
investig
rather
uniqu
model
system
investig
paramet
critic
affect
phenotyp
heterogen
often
associ
infect
viru
effort
develop
arenaviru
vaccin
focus
junv
lasv
caus
agent
ahf
lf
live
attenu
candid
strain
junv
shown
induc
strong
neutral
antibodi
respons
sever
anim
model
well
human
correl
protect
highli
virul
strain
junv
enria
barrera
oro
enria
et
al
doubl
blind
studi
involv
agricultur
worker
endem
area
argentin
candid
strain
prove
effect
vaccin
without
seriou
advers
effect
maiztegui
et
al
howev
candid
vaccin
licens
investig
new
drug
us
studi
address
stabil
attenu
longterm
immun
safeti
conduct
sequenc
comparison
candid
virul
strain
junv
shown
multipl
mutat
within
np
gp
l
associ
vaccin
strain
rel
contribut
attenu
determin
lasv
arenaviru
highest
impact
public
health
due
high
incid
within
vast
endem
area
west
africa
estim
viru
exposur
base
antibodi
preval
rang
guinea
nigeria
khan
et
al
therefor
develop
effect
safe
vaccin
would
repres
major
accomplish
west
africa
also
geograph
region
due
risk
import
case
lf
pose
increas
intern
travel
contrari
situat
found
junv
ahf
neutral
antibodi
respons
predict
surviv
lf
mccormick
fisherhoch
therefor
like
mechan
respons
success
junv
candid
strain
vaccin
ahf
may
serv
purpos
case
lf
differ
approach
pursu
aim
develop
safe
effect
vaccin
lasv
includ
dna
immun
protocol
rodriguezcarreno
et
al
use
recombin
salmonella
djavani
et
al
recombin
vaccinia
virus
express
lasv
np
gp
shown
provid
guinea
pig
nonhuman
primat
protect
cellmedi
immun
lethal
challeng
fisherhoch
et
al
howev
high
preval
hiv
west
africa
safeti
profil
vaccinia
viru
rais
seriou
doubt
potenti
implement
approach
alphavirusbas
vector
use
induc
protect
immun
guinea
pig
pushko
et
al
recent
recombin
vesicular
stomat
viru
vsv
lasv
gp
replac
vsv
g
shown
provid
protect
lethal
challeng
geisbert
et
al
studi
lasv
challeng
done
day
immun
remain
determin
whether
recombin
vaccin
provid
longterm
protect
highli
relev
issu
due
cumul
lifetim
risk
exposur
lf
vaccin
within
west
africa
human
popul
anoth
approach
pursu
develop
vaccin
lf
induct
heterolog
immun
use
close
relat
less
pathogen
viru
thu
lcmv
shown
abl
protect
nonhuman
primat
lf
kiley
et
al
recent
reassort
viru
lasv
genet
close
relat
nw
arenaviru
mopeia
mopv
call
found
protect
guinea
pig
lasv
induc
diseas
lukashevich
et
al
howev
safeti
profil
lcmv
mopv
human
determin
develop
revers
genet
system
junv
lasv
similar
one
describ
lcmv
would
facilit
elucid
genet
determin
junv
lasv
virul
turn
help
design
safer
live
attenu
vaccin
minim
concern
relat
possibl
revers
virul
establish
persist
infect
gener
condit
associ
high
risk
replic
virus
includ
immunocompromis
individu
power
revers
genet
tool
arenaviru
vaccin
develop
illustr
recent
find
obtain
recombin
lcmv
express
surfac
gp
vsv
serotyp
indiana
instead
gp
rlcmvindg
pinschew
et
al
mice
rlcmvindg
exhibit
highli
attenu
phenotyp
remain
stabl
upon
longterm
propag
immunocompromis
mice
abl
elicit
strong
longterm
cellmedi
immun
lethal
challeng
wildtyp
lcmv
current
therapeut
measur
ahf
center
around
transfus
immun
plasma
defin
dose
neutral
antibodi
prodrom
phase
ill
enria
et
al
complic
difficulti
maintain
appropri
stock
immun
plasma
difficulti
detect
ahf
earli
stage
immun
plasma
therapi
exert
maxim
efficaci
vitro
vivo
studi
document
prophylact
therapeut
valu
nucleosid
analogu
ribavirin
rib
sever
arenavirus
andrei
de
clercq
damont
coto
moreov
rib
shown
reduc
significantli
morbid
mortal
human
associ
lasv
mccormick
et
al
andrei
de
clercq
damont
coto
experiment
machupo
kilgor
et
al
junv
infect
mckee
et
al
given
earli
cours
clinic
diseas
mechan
rib
exert
antiarenavir
action
remain
poorli
understood
like
involv
target
differ
step
viru
life
cycl
parker
leyssen
et
al
recent
evid
indic
rib
use
substrat
rdrp
ribovirus
lead
c
u
g
transit
crotti
et
al
cameron
castro
parker
mutagen
activ
rib
link
antivir
activ
via
lethal
mutagenesi
cameron
castro
howev
rib
inhibit
strongli
lcmv
replic
without
exert
notic
mutagen
effect
viru
genom
rna
ruizjarabo
et
al
human
treatment
caus
revers
anemia
drug
also
caus
birth
defect
laboratori
anim
may
prescrib
pregnant
women
addit
oral
rib
significantli
less
effect
one
administ
intraven
pose
logist
complic
region
limit
clinic
infrastructur
sever
ribrel
inhibitor
imp
dehydrogenas
includ
ribamidin
andrei
de
clercq
well
acycl
carbocycl
adenosin
analogu
inhibitor
sadenosylhomocystein
sah
hydrolas
andrei
de
clercq
show
antiarenaviru
activ
moreov
varieti
sulfat
polysaccharid
exhibit
signific
specif
antiarenaviru
activ
andrei
de
clercq
likewis
phenotiazin
compound
candurra
et
al
myrist
acid
analogu
cordo
et
al
well
brassinosteroid
wachsman
et
al
report
activ
sever
arenavirus
gener
compound
display
modest
rather
nonspecif
effect
often
associ
signific
toxic
recent
highthroughput
screen
ht
base
virusinduc
cytopath
effect
cpe
assay
success
identifi
potent
smallmolecul
inhibitor
hf
new
world
arenavirus
act
target
viral
gp
bolken
et
al
likewis
cellbas
ht
base
use
pseudotyp
virion
particl
bear
gp
highli
pathogen
arenavirus
identifi
sever
smallmolecul
inhibitor
viru
cell
entri
mediat
lasv
gp
find
illustr
complex
chemic
librari
use
context
appropri
screen
assay
har
power
tool
identifi
candid
antivir
drug
highli
specif
activ
goal
recent
progress
molecular
cell
biolog
arenavirus
includ
develop
revers
genet
system
open
new
avenu
identif
step
arenaviru
life
cycl
amen
drug
target
develop
appropri
screen
strategi
identifi
drug
arenavirus
envelop
virus
biseg
negativesens
singlestrand
rna
genom
life
cycl
restrict
cell
cytoplasm
genom
rna
segment
l
ca
kb
ca
kb
use
ambisens
code
strategi
direct
synthesi
two
polypeptid
opposit
orient
separ
noncod
intergen
region
term
igr
predict
fold
stabl
hairpin
structur
fig
rna
encod
viral
nucleoprotein
np
ca
kda
virion
surfac
glycoprotein
precursor
gpc
ca
kda
l
rna
encod
viral
rnadepend
rna
polymeras
rdrp
l
polymeras
ca
kda
small
ring
finger
protein
z
ca
kda
viral
mrna
extra
nontempl
nucleotid
nt
appear
cap
structur
end
origin
cap
nontempl
nt
extens
remain
determin
np
l
polypeptid
translat
mrna
antigenom
sens
polar
wherea
gpc
z
orf
translat
directli
genom
rna
speci
rather
genomesens
mrna
transcrib
use
templat
l
antigenom
rna
speci
respect
transcript
termin
subgenom
nonpolyadenyl
viral
mrna
map
multipl
site
within
distal
side
intergen
region
igr
suggest
igr
act
bona
fide
transcript
termin
viral
polymeras
confirm
recent
studi
use
revers
genet
approach
pinschew
et
al
lopez
franzefernandez
posttransl
cleavag
gpc
gener
three
compon
form
gp
complex
gpc
stabl
signal
peptid
ssp
mr
kda
mr
kda
arenaviru
ssp
uniqu
remain
stabli
associ
gp
complex
follow
cleavag
signal
peptidas
play
crucial
role
traffick
gp
secretori
pathway
eichler
et
al
york
et
al
gener
ow
arenavirus
lcmv
lasv
found
mediat
cellular
proteas
beyer
et
al
kunz
et
al
pinschew
et
al
find
extend
nw
arenavirus
guanarito
machupo
junin
notabl
proteas
recognit
site
present
guanarito
gpc
deviat
origin
report
consensu
sequenc
indic
specif
broader
previous
thought
surfac
viru
envelop
decor
evenli
space
project
spike
consist
complex
locat
top
spike
held
place
ionic
interact
nterminu
transmembran
form
stalk
spike
neuman
et
al
buchmeier
et
al
virion
attach
protein
mediat
viru
interact
host
cell
surfac
receptor
subsequ
viru
cell
entri
via
receptor
mediat
endocytosi
kunz
et
al
viral
ribonucleoprotein
deliv
cytoplasm
infect
cell
associ
polymeras
direct
biosynthet
process
involv
rna
replic
gene
transcript
fig
primari
transcript
initi
genom
promot
locat
genom
end
result
synthesi
np
l
mrna
l
segment
respect
subsequ
viru
polymeras
adopt
replicas
mode
move
across
igr
gener
copi
fulllength
antigenom
rna
agrna
agrna
serv
templat
synthesi
gp
ag
z
agl
mrna
agrna
speci
serv
also
templat
amplif
correspond
genom
rna
speci
assembl
cell
releas
infecti
progeni
involv
associ
viral
ribonucleoprotein
core
surfac
gp
complex
process
requir
particip
z
capul
et
al
correct
process
gpc
requir
product
basic
aspect
arenaviru
rna
replic
gene
transcript
illustr
segment
l
polymeras
associ
viru
rnp
initi
transcript
genom
promot
locat
genom
end
primari
transcript
result
synthesi
np
mrna
l
mrna
case
l
segment
subsequ
viru
polymeras
adopt
replicas
mode
move
across
igr
gener
copi
fulllength
antigenom
ag
rna
ag
l
rna
ag
rna
serv
templat
synthesi
gp
mrna
ag
l
rna
serv
templat
synthesi
z
mrna
agrna
speci
serv
also
templat
amplif
correspond
genom
rna
speci
infecti
virion
beyer
et
al
kunz
et
al
pinschew
et
al
bud
plasma
membran
segment
natur
arenaviru
genom
permit
gener
reassort
two
parent
virus
cell
coinfect
virus
serv
mix
vessel
facilit
gener
infecti
progeni
carri
possibl
combin
ls
genom
genet
biochem
character
clonal
popul
deriv
infecti
progeni
make
possibl
identifi
origin
rna
segment
therebi
map
specif
phenotyp
parent
virus
either
l
segment
exampl
abil
lcmv
caus
growth
hormon
defici
mice
rivier
et
al
immunosuppress
persist
adult
immunocompet
mice
matloubian
et
al
salvato
et
al
map
segment
similarli
lethal
strain
lcmv
guinea
pig
rivier
et
al
differ
virul
lasv
strain
lukashevich
et
al
map
l
segment
despit
tremend
success
map
varieti
arenaviru
phenotyp
either
l
segment
use
reassort
virus
make
possibl
assess
individu
contribut
potenti
multipl
mutat
often
found
l
segment
two
parent
virus
likewis
reassort
approach
use
gener
virus
predetermin
mutat
genom
inabl
genet
manipul
arenaviru
genom
hamper
studi
aim
understand
molecular
cell
biolog
well
role
play
viral
gene
product
virushost
interact
acut
persist
infect
associ
diseas
revers
genet
system
support
rna
replic
express
arenaviru
minigenom
develop
lcmv
well
lasv
hass
et
al
nw
arenaviru
tacarib
tcv
lopez
et
al
provid
investig
novel
power
approach
investig
transact
factor
cisact
sequenc
control
arenaviru
replic
gene
express
well
assembl
bud
fig
lcmv
mg
system
base
intracellular
synthesi
via
either
plasmidsuppli
rna
polymeras
rna
polymeras
poli
rna
analogu
mg
contain
utr
igr
cisact
sequenc
requir
control
rna
synthesi
mediat
lcmv
polymeras
orf
report
gene
lieu
np
orf
encapsid
poli
lcmv
mg
rna
plasmidsuppli
np
gener
templat
recogn
intracellularli
reconstitut
lcmv
polymeras
direct
synthesi
fulllength
antiminigenom
amg
rna
replic
subgenom
mrna
transcript
code
report
gene
choic
lee
et
al
incorpor
transfect
mix
gpc
zexpress
plasmid
allow
assembl
bud
infecti
vlp
lee
et
al
perez
et
al
result
lcmv
mg
system
identifi
np
l
minim
viral
transact
factor
requir
effici
rna
synthesi
transcript
replic
mediat
viru
polymeras
lee
et
al
similar
find
document
lasv
hass
et
al
tcv
lopez
et
al
notabl
genet
biochem
evid
indic
oligomer
l
requir
polymeras
function
activ
lcmv
genom
promot
recogn
viru
polymeras
requir
sequenc
specif
within
highli
conserv
termin
nt
arenaviru
genom
integr
predict
panhandl
structur
form
via
sequenc
complementar
viral
genom
rna
detail
structurefunct
studi
use
lasv
mg
system
hass
et
al
reveal
lasv
promot
like
arenavirus
regul
transcript
replic
coordin
manner
compos
two
function
element
sequencespecif
region
residu
variabl
complementari
region
residu
first
region
appear
interact
replic
complex
mainli
via
basespecif
interact
second
region
base
pair
termini
promot
determin
activ
use
lcmv
mg
rescu
system
also
provid
direct
experiment
evid
igr
bona
fide
transcript
termin
signal
pinschew
et
al
find
also
document
tcv
contrari
wide
accept
model
control
arenaviru
rna
replic
gene
transcript
intracellular
level
np
play
key
role
control
balanc
rna
replic
transcript
arenaviru
polymeras
pinschew
et
al
mechan
determin
whether
arenaviru
polymeras
complex
behav
replicas
transcriptas
mode
remain
elucid
z
requir
intracellular
transcript
replic
lcmv
mg
rather
z
exhibit
dosedepend
inhibitori
effect
transcript
replic
lcmv
mg
lee
et
al
de
la
torr
cornu
et
al
inhibitori
effect
z
also
report
tav
lopez
et
al
lasv
hass
et
al
z
postul
particip
virion
morphogenesi
salvato
et
al
salvato
envelop
virus
matrix
protein
involv
organ
virion
compon
prior
assembl
arenavirus
obviou
counterpart
howev
perez
et
al
other
urata
et
al
shown
z
main
drive
forc
arenaviru
bud
process
mediat
z
prolinerich
late
domain
motif
ldm
ptap
pppi
similar
known
control
bud
sever
virus
includ
hiv
ebola
via
interact
specif
host
cell
protein
freed
consist
observ
z
exhibit
featur
characterist
bona
fide
bud
protein
abil
bud
cell
effici
substitut
ldm
perez
et
al
target
z
plasma
membran
locat
arenaviru
bud
strictli
requir
myristoyl
perez
et
al
data
support
role
z
arenaviru
counterpart
protein
found
mani
ns
rna
virus
notion
consist
recent
ultrastructur
data
arenaviru
virion
determin
cryoelectron
microscopi
neuman
et
al
infecti
lcmv
rescu
entir
clone
cdna
use
approach
base
rna
polymeras
sanchez
de
la
torr
rna
poli
flatz
et
al
launch
intracellular
synthesi
l
antigenom
rna
speci
subsequ
replic
transcrib
viru
polymeras
intracellularli
reconstitut
via
plasmidsuppli
viral
l
np
fig
abil
gener
rlcmv
predetermin
specif
mutat
analyz
phenotyp
express
natur
host
mous
would
allow
us
tackl
number
fig
rescu
infecti
rlcmv
entir
clone
cdna
cell
transfect
plasmid
direct
poli
mediat
intracellular
synthesi
l
antigenom
lag
sag
rna
speci
togeth
polii
express
plasmid
viral
transact
factor
l
np
also
requir
differ
time
transfect
cell
cultur
supernat
test
product
infecti
rlcmv
product
rlcmv
readili
consist
detect
h
transfect
follow
rapid
increas
viru
product
reach
titer
pfuml
h
posttransfect
notabl
observ
similar
rescu
effici
use
either
genom
antigenom
polar
l
rna
find
indic
anneal
viral
mrna
genom
antigenom
rna
speci
pose
signific
problem
rescu
lcmv
like
arenavirus
gener
likewis
poli
base
rescu
system
exhibit
similar
effici
longstand
question
viru
molecular
biolog
relationship
host
cell
specif
role
four
known
viral
gene
arenaviru
pathogenesi
mg
rescu
system
similar
alreadi
establish
lcmv
lasv
tcv
could
develop
arenavirus
interest
mg
system
provid
investig
excel
platform
identifi
inhibitor
arenaviru
replic
propag
dissect
mechan
action
thu
antiarenaviru
activ
rib
recreat
lcmv
ruizjarabo
et
al
lasv
hass
et
al
mg
rescu
system
contrast
myristoyl
inhibitor
acid
shown
inhibit
zmediat
arenaviru
bud
perez
et
al
affect
predict
mg
rna
replic
express
support
feasibl
use
cellbas
mg
rescu
system
identifi
drug
interfer
specif
step
arenaviru
life
cycl
subsequ
delin
underli
mechan
action
likewis
use
lcmv
mg
system
instrument
assess
specif
efficaci
effect
sirna
target
differ
viral
mrna
follow
section
discuss
exampl
use
mg
system
uncov
novel
antiarenavir
strategi
sequenc
structur
constraint
arenaviru
genom
promot
perez
de
la
torr
identifi
new
potenti
target
drug
capabl
disrupt
interact
promot
viru
polymeras
complex
expect
strong
deleteri
impact
viru
viabil
affect
essenti
biosynthet
process
viral
transcript
replic
potenti
rna
prime
target
therapeut
intervent
gain
great
interest
hermann
hermann
westhof
wilson
li
sucheck
shue
function
mani
rna
molecul
depend
defin
threedimension
structur
larg
varieti
structur
associ
rna
fold
creat
uniqu
bind
pocket
provid
potenti
target
small
molecul
small
molecul
may
interfer
rna
function
number
mechan
includ
inhibit
format
compet
rnaprotein
complex
studi
smallmolecul
rna
effector
primarili
focus
aminoglycosid
hermann
hermann
westhof
wilson
li
sucheck
shue
antibiot
activ
associ
aminoglycosid
target
bacteri
ribosom
rna
wellknown
success
case
despit
benefit
efficaci
natur
occur
aminoglycosid
limit
due
emerg
resist
microb
oral
inact
toxic
weak
bind
common
carbohydr
recent
year
great
progress
develop
aminoglycosidebas
analogu
mimet
circumv
issu
wong
ye
zhang
advanc
permit
gener
complex
combinatori
librari
aminoglycosid
subject
robust
novel
screen
procedur
hermann
hermann
westhof
wilson
li
sear
wong
sucheck
shue
ye
zhang
develop
facilit
identif
drug
bind
specif
varieti
rna
fold
thu
open
new
way
expand
exist
repertoir
proteintarget
therapeut
potenti
aminoglycosid
antivir
molecul
act
rna
illustr
abil
disrupt
select
revrr
zapp
et
al
tattar
wang
et
al
interact
similar
approach
could
use
select
aminoglycosid
interact
arenaviru
promot
disrupt
activ
sequenc
conserv
arenaviru
promot
predict
aminoglycosidebas
small
molecul
select
base
activ
promot
prototyp
arenaviru
lcmv
would
also
activ
lasv
hf
arenavirus
high
sequenc
structur
conserv
core
arenaviru
genom
promot
rais
also
possibl
use
method
vitro
select
combinatori
oligonucleotid
librari
refer
selex
systemat
evolut
ligand
exponenti
enrich
ellington
szostak
robertson
joyc
tuerk
gold
select
nucleic
acidbas
molecul
aka
aptam
target
protein
aptam
usual
exhibit
tight
bind
protein
target
high
specif
minim
immunogen
therefor
consid
novel
promis
therapeut
drug
selex
could
use
select
aptam
molecul
target
arenaviru
l
polymeras
disrupt
either
lviru
promot
interact
strictli
requir
initi
rna
synthesi
earli
studi
document
end
nonpolyadenyl
lcmv
mrna
heterogen
map
within
igr
meyer
et
al
arenaviru
igr
sequenc
predict
fold
singl
doubl
stemloop
structur
meyer
et
al
buchmeier
et
al
suggest
structuredepend
transcript
termin
mechan
reminisc
rhoindepend
termin
prokaryot
yarnel
robert
tortorici
et
al
predict
receiv
direct
experiment
support
result
obtain
use
arenaviru
mg
system
pinschew
et
al
lopez
franzefernandez
unexpectedli
lcmv
mg
without
igr
dramat
impair
abil
passag
report
gene
activ
via
infecti
vlp
pinschew
et
al
suggest
addit
role
control
rna
synthesi
igr
play
role
viru
assembl
bud
requir
effici
propag
lcmv
infect
regard
worth
note
lcmv
genom
antigenom
rna
speci
present
arenaviru
rnp
found
sensit
cleavag
low
concentr
rnase
suggest
arenaviru
genom
antigenom
tightli
encapsid
therebi
potenti
vulner
target
signific
sequenc
heterogen
igr
l
segment
arenaviru
speci
l
segment
differ
speci
howev
viru
genom
promot
igr
predict
conserv
fold
could
provid
suitabl
target
arenaviru
l
protein
characterist
sequenc
motif
conserv
among
rdrp
l
protein
ns
rna
virus
sequenc
align
show
six
conserv
domain
poch
et
al
tordo
et
al
propos
polymeras
modul
l
locat
within
domain
iii
contain
highli
conserv
amino
acid
within
motif
design
c
sdd
sequenc
characterist
motif
c
segment
ns
rna
virus
presenc
highli
conserv
residu
within
motif
strictli
requir
function
lcmv
l
polymeras
studi
also
show
mani
mutant
l
protein
exhibit
strong
dominantneg
dn
effect
assay
condit
wildtyp
mutant
l
protein
compet
templat
rna
viral
cellular
transact
protein
requir
polymeras
activ
result
highli
suggest
interact
requir
lcmv
polymeras
activ
consist
genet
data
result
coimmunoprecipit
studi
use
l
protein
contain
two
differ
tag
ha
flag
provid
biochem
evid
interact
intragen
complement
document
l
gene
sever
ns
rna
virus
repik
et
al
smallwood
et
al
consist
direct
physic
interact
demonstr
paramyxovirus
sendai
smallwood
et
al
parainfluneza
viru
smallwood
moyer
l
oligomer
requir
polymeras
activ
result
suggest
disrupt
interact
would
potent
inhibitori
effect
polymeras
activ
cellbas
mg
rescu
assay
particularli
appeal
identifi
small
molecul
capabl
disrupt
interact
thu
result
inhibit
arenaviru
polymeras
activ
proteinprotein
interact
gener
regard
difficult
refractori
drug
target
small
molecul
wide
share
assumpt
unlik
disturb
larg
protein
interfac
howev
recent
evid
suggest
affin
interact
protein
may
govern
minor
part
interfac
region
well
de
vo
target
highli
local
surfac
may
suffici
inhibit
proteinprotein
interact
notabl
combinatori
librari
small
molecul
gener
via
solutionphas
methodolog
uniqu
success
identif
small
molecul
inhibit
proteinprotein
interact
seri
signific
biolog
target
boger
et
al
boger
similar
approach
applic
screen
identifi
smallmolecul
inhibitor
arenaviru
polymeras
proteas
encod
membran
bound
transcriptionfactor
proteas
site
gene
endoplasm
reticulum
er
earli
golgi
membraneanchor
serin
proteas
sakai
et
al
seidah
et
al
cleav
within
motif
rx
hydrophob
xi
despit
broad
consensu
sequenc
exhibit
exquisit
substrat
specif
involv
proteolyt
process
defin
set
cellular
protein
includ
brain
deriv
neurotroph
factor
bdnf
precursor
protein
seidah
et
al
sterol
regulatori
elementbind
protein
membraneassoci
transcript
factor
regul
gene
involv
lipid
metabol
cholesterol
synthesi
brown
goldstein
goldstein
et
al
rawson
b
contribut
also
regul
transcript
factor
control
unfold
protein
respons
upr
cell
bring
fold
capac
er
line
fold
demand
ye
et
al
schroder
kaufman
process
gp
ow
arenavirus
lcmv
lasv
shown
crucial
product
infecti
progeni
celltocel
propag
lenz
et
al
beyer
et
al
kunz
et
al
pinschew
et
al
notabl
studi
lcmv
junv
infect
cell
defici
indic
emerg
variant
capabl
grow
independ
process
gpc
appear
highli
unlik
kunz
de
la
torr
unpublish
find
strongli
support
view
inhibitor
proteas
repres
promis
drug
candid
worth
note
also
mediat
process
major
gp
precursor
crimeancongo
hemorrhag
fever
viru
cchfv
member
nairoviru
genu
famili
bunyavirida
sanchez
et
al
vincent
et
al
therefor
compound
exert
antiarenavir
activ
inhibit
process
viru
gpc
precursor
would
like
effect
also
cchfv
tickborn
pathogen
caus
hf
human
throughout
region
africa
asia
europ
key
role
regul
lipid
metabol
cholesterol
biosynthesi
rais
consider
interest
develop
specif
inhibitor
activ
nonpeptid
gener
serin
proteas
inhibitor
aminoethyl
benzenesulfonyl
fluorid
aebsf
report
inhibit
basak
et
al
studi
question
find
elagoz
et
al
bodvard
et
al
block
specif
inhibitor
proprotein
convertas
dci
low
nanomolar
concentr
effici
inhibit
bodvard
et
al
likewis
mutant
preproseg
variant
serpin
design
react
insert
reactiv
loop
sequenc
also
evalu
candid
proteinbas
inhibitor
pullikotil
et
al
studi
identifi
sever
molecul
significantli
block
process
gp
cchf
viru
express
cell
provid
proofofprincipl
recent
effort
focus
develop
peptidebas
irrevers
inhibitor
identifi
decanoyl
chloromethylketon
cmk
derivat
peptid
contain
rrll
recognit
sequenc
potent
suicid
inhibitor
pasquato
et
al
inhibitor
also
block
activ
furin
vitro
show
specif
toward
use
cell
caus
irrevers
inhibit
catalyt
activ
target
whether
host
cell
pathogenderiv
use
would
pose
difficulti
therapeut
approach
aim
specif
inhibit
process
viral
gp
without
affect
activ
toward
cellular
substrat
consequ
strategi
aim
target
process
arenaviru
gpc
pursu
identif
compound
specif
block
process
arenaviru
gpc
mani
virus
includ
japanes
enceph
su
et
al
murin
retrovirus
dimcheff
et
al
dimcheff
et
al
hepat
c
pavio
et
al
paramyxovirus
sun
et
al
human
cytomegaloviru
isler
et
al
sar
corona
viru
versteeg
et
al
west
nile
viru
medigeshi
et
al
induc
upr
express
viral
envelop
gp
er
often
major
trigger
upr
due
overwhelm
fold
capac
er
result
accumul
unfold
viral
gp
aspect
upr
increas
er
fold
capac
metabol
adapt
like
favor
viral
infect
other
suppress
protein
translat
increas
er
protein
degrad
appear
disadvantag
noncytoly
virus
arenavirus
readili
persist
may
evolv
mechan
differenti
modul
differ
branch
upr
favor
viral
replic
gene
express
maintain
aspect
upr
benefici
host
cell
arenavirus
may
evolv
use
instead
proteas
proprotein
convertas
famili
commonli
use
process
viral
gp
eg
furin
interact
gp
allow
viru
manipul
host
cell
upr
featur
could
pose
addit
barrier
emerg
viral
variant
capabl
use
altern
proteas
process
gpc
would
enhanc
antivir
power
inhibitor
bona
fide
viral
bud
protein
zmediat
bud
arenavirus
requir
interact
z
specif
cellular
factor
within
endosomalmvb
pathway
pornillo
et
al
identif
character
lfv
zhost
protein
interact
involv
viru
bud
may
uncov
novel
antivir
target
facilit
develop
screen
strategi
identifi
drug
capabl
disrupt
bud
prevent
viru
propag
regard
alreadi
identifi
member
respect
escrti
escrtiii
complex
zinteract
cellular
protein
requir
bud
notabl
downregul
via
sirna
perez
et
al
use
dominantneg
form
perez
de
la
torr
unpublish
result
dramat
reduc
level
zmediat
bud
abil
z
direct
selfbud
absenc
viral
protein
facilit
develop
assay
amen
genet
chemic
ht
identifi
host
cellular
protein
requir
zmediat
bud
well
smallmolecul
inhibitor
process
end
emerg
rna
interfer
pathway
allow
modul
gene
express
enabl
function
genet
screen
mammalian
cell
type
azablanc
et
al
bern
et
al
paddison
et
al
likewis
combinatori
chemic
librari
emerg
lead
sourc
compound
screen
identifi
smallmolecul
inhibitor
zmediat
bud
use
cellbas
assay
method
current
use
assess
bud
mediat
wildtyp
mutant
viral
protein
reli
mainli
recoveri
highspe
ultracentrifug
immunoprecipit
vlp
present
cultur
supernat
cell
previous
transfect
plasmid
express
protein
interest
presenc
correspond
protein
recov
vlp
detect
base
use
radiolabel
protein
western
blot
use
appropri
antibodi
method
easili
amen
ht
identifi
inhibitor
zmediat
arenaviru
bud
ideal
ht
assay
would
permit
assess
z
bud
examin
tissu
cultur
supernat
directli
enzymat
assay
could
identifi
cellular
mediat
z
bud
recent
work
ebola
viru
describ
luciferasebas
bud
assay
might
suitabl
develop
ht
mccarthi
et
al
assay
howev
signific
limit
measur
incorpor
firefli
luciferas
ffl
vlp
therebi
directli
measur
bud
capabl
requir
ultracentrifug
vlp
detect
bud
result
howev
rais
possibl
use
chimer
protein
consist
bona
fide
viral
bud
protein
fuse
appropri
report
gene
ffl
tool
develop
assay
bud
could
rapidli
quantit
assess
measur
level
gene
report
activ
regard
recent
find
shown
fusion
smaller
amino
acid
luciferas
gaussia
princep
gluc
tannou
et
al
z
result
chimer
protein
zgluc
retain
wildtyp
z
bud
activ
could
monitor
direct
measur
gluc
activ
tc
zgluc
transfect
cell
aa
capul
jc
de
la
torr
manuscript
submit
initi
studi
shown
zgluc
base
bud
assay
consist
exhibit
high
averag
signaltonois
ratio
describ
ghosh
et
al
suggest
amen
develop
ht
identifi
smallmolecul
inhibitor
zmediat
bud
use
triseg
genom
strategi
incorpor
addit
gene
within
arenaviru
genom
two
segment
alter
replac
one
viral
orf
orf
gene
interest
goi
physic
separ
gp
np
two
differ
segment
would
repres
strong
select
pressur
select
maintain
viru
capabl
packag
l
segment
develop
ht
simultan
screen
broad
class
compound
function
multipl
viral
target
requir
complet
arenaviru
life
cycl
would
great
valu
identif
novel
antiarenavir
drug
aim
use
rlcmv
express
appropri
report
gene
facilit
develop
assay
amen
ht
format
varieti
recombin
lcm
virus
rlcmv
rescu
entir
clone
cdna
pinschew
et
al
flatz
et
al
sanchez
de
la
torr
contrast
rescu
rlcmv
express
addit
heterolog
gene
product
pose
unexpect
difficulti
sever
strategi
success
employ
ns
rna
virus
express
addit
gene
product
work
case
lcmv
emonet
jc
de
la
torr
unpublish
includ
incorpor
viru
genom
addit
transcript
unit
contain
orf
interest
use
viral
cellular
intern
ribosom
entri
site
ire
direct
capindepend
synthesi
protein
code
orf
locat
downstream
within
polycistron
mrna
use
selfcleav
proteas
picornavirus
effici
process
initi
synthes
polypeptid
gener
independ
protein
code
orf
locat
upand
downstream
recent
find
howev
support
feasibl
rescu
rlcmv
contain
three
genom
segment
l
emonet
jc
de
la
torr
unpublish
open
possibl
rescu
threeseg
rlcmv
two
segment
contain
gene
interest
goi
instead
one
either
gpc
np
rational
behind
approach
physic
separ
gp
np
two
differ
segment
would
repres
strong
select
pressur
select
maintain
viru
capabl
packag
l
segment
fig
strategi
use
gener
varieti
triseg
l
rlcmv
segment
one
two
viru
gene
gpc
np
replac
gene
interest
includ
report
gene
cat
luciferas
notabl
genotyp
growth
properti
report
gene
express
rlcmv
stabli
maintain
serial
passag
new
develop
provid
investig
fantast
tool
develop
ht
assay
global
identifi
inhibitor
arenaviru
multipl
find
describ
previou
section
illustr
potenti
use
arenaviru
mg
rescu
system
platform
drug
screen
mg
cellbas
assay
offer
number
benefit
discoveri
analysi
antivir
compound
permit
effect
antivir
compound
observ
context
live
cell
compound
show
antivir
activ
necessarili
abl
enter
act
within
live
cell
also
allow
immedi
identif
compound
undesir
cytotox
use
wellestablish
assay
viral
function
relat
infect
requir
mg
rna
replic
express
system
safer
easier
work
infecti
pathogen
arenavirus
worth
note
implement
sirnabas
screen
context
cellbas
mg
rescu
assay
identifi
host
cell
protein
play
key
role
arenaviru
rna
replic
gene
express
therebi
open
potenti
novel
target
could
use
develop
effect
antiarenavir
drug
abil
gener
rlcmv
predetermin
genet
modif
would
also
facilit
studi
aim
identifi
mechan
antivir
drug
action
possibl
gener
select
drugresist
viral
variant
develop
revers
genet
system
sever
arenavirus
also
open
new
research
avenu
studi
biolog
viru
famili
contain
sever
member
highli
relev
human
health
addit
prototyp
arenaviru
lcmv
remain
robust
model
system
studi
virushost
interact
context
infect
natur
host
mous
abil
manipul
lcmv
genom
gener
rlcmv
predetermin
mutat
allow
investig
gain
detail
understand
role
play
differ
viral
gene
specif
phenotyp
outcom
rang
acut
fatal
mening
immunosuppress
chronic
infect
associ
neurobehavior
abnorm
